To PEGylate or not to PEGylate: Immunological properties of nanomedicine’s most popular component, polyethylene glycol and its alternatives

Da Shi(Frederick National Laboratory for Cancer Research), Damian Beasock(University of North Carolina at Charlotte), Adam B. Fessler(University of North Carolina at Charlotte), János Szebeni(Semmelweis University), Julia Y. Ljubimova(Terasaki Foundation), Kirill A. Afonin(University of North Carolina at Charlotte), Marina A. Dobrovolskaia(Frederick National Laboratory for Cancer Research)
Advanced Drug Delivery Reviews
December 10, 2021
10.1016/j.addr.2021.114079
Cited by 491Open Access
Full Text

Abstract

Related Papers

No related papers found

Powered by citation graph analysis